SCHEMBL22815684

SCHEMBL22815684

CCOC(=O)c1nnn(Cc2ccc(OC)cc2)c1NCc1ccc(-c2ccc(Cl)c(Cl)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
RXFP1 Q9HBX9 1/20 0.47
ALOX15 P16050 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CYP19A1 P11511 7/20 0.46
MAPT P10636 2/20 0.44
PTGDR Q13258 1/20 0.44
AKR1C3 P42330 3/20 0.43
ALDH1A1 P00352 1/20 0.43
GABRA2 P47869 1/20 0.42
GABRB2 P47870 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HPGD P15428 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22815766 0.93 CYP19A1 (0.48) POLBRXFP1ALOX15L3MBTL1CYP19A1
SCHEMBL22816685 0.89 CYP19A1 (0.46) POLBRXFP1ALOX15L3MBTL1CYP19A1
SCHEMBL22815681 0.85 CYP19A1 (0.54) POLBRXFP1ALOX15L3MBTL1CYP19A1
SCHEMBL22816823 0.84 CYP19A1 (0.48) POLBRXFP1ALOX15L3MBTL1CYP19A1
SCHEMBL22816671 0.84 CYP19A1 (0.61) POLBRXFP1ALOX15L3MBTL1CYP19A1
SCHEMBL22816965 0.84 CYP19A1 (0.47) POLBRXFP1ALOX15L3MBTL1CYP19A1
SCHEMBL22816474 0.83 MEN1 (0.46) POLBRXFP1ALOX15L3MBTL1CYP19A1
SCHEMBL22816858 0.83 CYP19A1 (0.47) POLBRXFP1ALOX15L3MBTL1CYP19A1
SCHEMBL22816008 0.83 CYP19A1 (0.46) POLBRXFP1CYP19A1MAPTAKR1C3
SCHEMBL22815522 0.82 CYP19A1 (0.46) POLBRXFP1ALOX15L3MBTL1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020257487-A1 GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2020-12-24 WO disclosed